TETRA-ABC

Manufacturer: Phillips Company
Effective date: 2010-08-24
Label type: HUMAN OTC DRUG LABEL
Version: 3
Source: full-release
Hydrated at: 2026-05-31 22:25:37

Label at a glance#

ProductTETRA-ABC

Active ingredientTETRACYCLINE HYDROCHLORIDE

Label structure13 sections

Contacts and useful links#

PhoneLabel contact580-746-2430

Websitewww.phillipscompany.4t.com

www.PhillipsCompany.4T.com/CC.pdf

Label contents#

Full prescribing information#

DRUG FACTS

OTC - ACTIVE INGREDIENT SECTION

DRUG FACTS
Active Ingredient                           Purpose
Tetracycline (3%) ....................... First-aid antibiotic

Uses
First aid to help prevent skin infection in minor cuts, scrapes and burns
For external use only.
Keep away from children.
Do not use in the eyes or apply over large areas of the body.
May be harmful if swallowed.
In case of deep or puncture wounds, animal bites, or serious burns, consult a physician.
Stop use and consult a physician if the condition persists or gets worse.      Do not use if allergic to any ingredient listed on this label.
Do not use longer than 1 week. Discard this product 1 week after opening bottle.

Directions
Clean the affected area. Apply a small amount of this product (an amount equal to the surface area of the tip of a finger) on the area and rub gently using a cotton swab.    Repeat the process three times daily. Keep this product refrigerated to preserve effectiveness and color.

Other information
This product is an OTC antibiotic drug product for human use. This product contains no alcohol; no animal ingredients; no biological ingredients. Blended for typical skin color. May stain cloth.

Inactive ingredients
Water, glycerin, hydroxethylcellulose, chlor-hexidine gluconate, glucono delta lactone, methylparaben, sodium hydroxide, dipropylene glycol, dimethyl sulfoxide, sorbic acid, ascorbic acid, magnesium stearate, stearic acid.

Side effects
Same as other tetracycline products.
See listing of side effects online at
www.PhillipsCompany.4T.com/CC.pdf
Report any side effects to Phillips Company,
311 Chickasaw Street, Millerton, OK USA 74750
Tel. 580-746-2430.
Email: PhillipsCompany@cox.net

ACTIVE INGREDIENTS

OTC - ACTIVE INGREDIENT SECTION

Active Ingredient Purpose
Tetracycline (3%) ....................... First-aid antibiotic

ASK DOCTOR

OTC - ASK DOCTOR SECTION

ASK DOCTOR

In case of deep or puncture wounds, animal bites, or serious burns, consult a physician.
Stop use and consult a physician if the condition persists or gets worse.

DO NOT USE

OTC - DO NOT USE SECTION

For external use only.
Keep away from children.
Do not use in the eyes or apply over large areas of the body.
May be harmful if swallowed.
Do not use if allergic to any ingredient listed on this label.
Do not use longer than 1 week. Discard this product 1 week after opening bottle.

CHILDREN

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Keep away from children.
Discard this product 1 week after opening bottle.

PURPOSE

OTC - PURPOSE SECTION

Active Ingredient Purpose
Tetracycline (3%) ....................... First-aid antibiotic

STOP USE

OTC - STOP USE SECTION

Stop use and consult a physician if the condition persists or gets worse.

Do not use if allergic to any ingredient listed on this label.

Do not use longer than 1 week. Discard this product 1 week after opening bottle.

WHEN USING

OTC - WHEN USING SECTION

First aid to help prevent skin infection in minor cuts, scrapes and burns

In case of deep or puncture wounds, animal bites, or serious burns, consult a physician.

WARNINGS

WARNINGS SECTION

Side effects: same as other tetracycline products.
See listing of side effects online at www.PhillipsCompany.4T.com/CC.pdf
Report any side effects to Phillips Company, 311 Chickasaw Street, Millerton, OK USA 74750
Tel. 580-746-2430. Email: PhillipsCompany@cox.net

DOSAGE & ADMINISTRATION

DOSAGE & ADMINISTRATION SECTION

Clean the affected area. Apply a small amount of this product (an amount equal to the surface area of the tip of a finger) on the area and rub gently using a cotton swab. Repeat the process three times daily. Keep this product refrigerated to preserve effectiveness and color.

USE

INDICATIONS & USAGE SECTION

Uses
First aid to help prevent skin infection in minor cuts, scrapes and burns
For external use only.
Keep away from children.
Do not use in the eyes or apply over large areas of the body.
May be harmful if swallowed.
In case of deep or puncture wounds, animal bites, or serious burns, consult a physician.
Stop use and consult a physician if the condition persists or gets worse.        Do not use if allergic to any ingredient listed on this label.
Do not use longer than 1 week. Discard this product 1 week after opening bottle.

INACTIVE INGREDIENTS

INACTIVE INGREDIENT SECTION

Water, glycerin, hydroxethylcellulose, chlorhexidine gluconate, glucono delta lactone, methylparaben, sodium hydroxide, dipropylene glycol, dimethyl sulfoxide, sorbic acid, ascorbic acid, magnesium stearate, stearic acid.

Image of product

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Image of product

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	SPL version
1542813	tetracycline HCl 3 % Topical Ointment	PSN	3
1542813	tetracycline hydrochloride 0.03 MG/MG Topical Ointment	SCD	3
1542813	tetracycline HCl 3 % Topical Ointment	SY	3

DailyMed Pharmacologic Classes#

Class, Version, Type table
Class	Version	Type	Effective
TETRACYCLINE Pharmacologic Class Indexing	2	Indexing - Pharmacologic Class	20180813

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
bee4fa8d-8d82-423a-a0b5-40a89dd13a99	Product name	1	20250618
0be8e4ae-4d57-49f3-b3a9-e4728b4e8d15	Product name	1	20240313
6c13b22c-b3ba-4127-b768-0132dd5ab0d1	Product name	1	20230829
151122cd-8b80-4972-8b02-3a4dda642fbc	Product name	2	20200701
dea2eded-d1e7-46bb-9a3d-f8dc20de6277	Product name	1	20190408
bb6d6c68-649d-4e6d-a1f6-603d969c8f68	Product name	1	20160303

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDC	Effective	Action	Document	Indexing SPL	Related label
43074-103-02	2019-10-21	C162847	48780-1	956f9ecf-db42-621f-e053-dbdaa90a74ad	DRUG FACTS

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
43074-103-01	TETRA-ABC	3 mL in 1 BOTTLE, DROPPER	OINTMENT	3		3
43074-103-02	TETRA-ABC	1 in 1 BOTTLE, PLASTIC	OINTMENT	1		3

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
43074-103	TETRA-ABC (TETRACYCLINE HYDROCHLORIDE) OINTMENT [PHILLIPS COMPANY]	3	Legacy NDC, 2 package rows	20100826_9b3c7b34-abd9-417b-a2e9-b7e857339ff5.zip

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	SPL version
TETRACYCLINE HYDROCHLORIDE	ACTIVE INGREDIENT	P6R62377KV	3
TETRACYCLINE	ACTIVE MOIETY	F8VB5M810T	3
calcium gluconate	INACTIVE INGREDIENT	SQE6VB453K	3
CHLORHEXIDINE GLUCONATE	INACTIVE INGREDIENT	MOR84MUD8E	3
dipropylene glycol	INACTIVE INGREDIENT	E107L85C40	3
glycerin	INACTIVE INGREDIENT	PDC6A3C0OX	3
magnesium stearate	INACTIVE INGREDIENT	70097M6I30	3
methylparaben	INACTIVE INGREDIENT	A2I8C7HI9T	3
sodium hydroxide	INACTIVE INGREDIENT	55X04QC32I	3
sorbic acid	INACTIVE INGREDIENT	X045WJ989B	3
stearic acid	INACTIVE INGREDIENT	4ELV7Z65AP	3
Water	INACTIVE INGREDIENT	059QF0KO0R	3

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 13 matching rows.

TETRA-ABC
TETRACYCLINE HYDROCHLORIDE
TETRACYCLINE
dipropylene glycol
Water
glycerin
CHLORHEXIDINE GLUCONATE
calcium gluconate
methylparaben
sodium hydroxide
sorbic acid
magnesium stearate
stearic acid

NDC Codes#

Product NDC, Package NDC table
Product NDC	Package NDC
43074-103	43074-103-01, 43074-103-02

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 11 matching rows.

Name, UNII, Kind table
Name	UNII	Kind
TETRACYCLINE HYDROCHLORIDE	P6R62377KV	ACTIM
dipropylene glycol	E107L85C40	IACT
Water	059QF0KO0R	IACT
glycerin	PDC6A3C0OX	IACT
CHLORHEXIDINE GLUCONATE	MOR84MUD8E	IACT
calcium gluconate	SQE6VB453K	IACT
methylparaben	A2I8C7HI9T	IACT
sodium hydroxide	55X04QC32I	IACT
sorbic acid	X045WJ989B	IACT
magnesium stearate	70097M6I30	IACT
stearic acid	4ELV7Z65AP	IACT

Source Document#

Source XML

Inactive ingredient matches#

Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.

Inactive ingredient links page 1 of 7 · 415 matching rows.

DailyMed ingredient, IID ingredient, UNII table
DailyMed ingredient	IID ingredient	UNII	Dosage form / route	Potency	Maximum daily exposure	Match
glycerin	GLYCERIN	PDC6A3C0OX	CAPSULE, COATED / ORAL	14.21 mg		Exact identifier — unii candidate 75 equally ranked IID candidates
methylparaben	METHYLPARABEN	A2I8C7HI9T	SOLUTION / TOPICAL		216 mg	Exact identifier — unii candidate 79 equally ranked IID candidates
sodium hydroxide	SODIUM HYDROXIDE	55X04QC32I	EMULSION / TOPICAL	0.2 %w/w		Exact identifier — unii candidate 174 equally ranked IID candidates
sodium hydroxide	SODIUM HYDROXIDE	55X04QC32I	SOLUTION / IONTOPHORESIS	ADJ PH		Exact identifier — unii candidate 174 equally ranked IID candidates
sodium hydroxide	SODIUM HYDROXIDE	55X04QC32I	SOLUTION/ DROPS / TOPICAL	ADJ PH		Exact identifier — unii candidate 174 equally ranked IID candidates
methylparaben	METHYLPARABEN	A2I8C7HI9T	SUPPOSITORY / VAGINAL	NA		Exact identifier — unii candidate 79 equally ranked IID candidates
methylparaben	METHYLPARABEN	A2I8C7HI9T	SUSPENSION / AURICULAR (OTIC)	NA		Exact identifier — unii candidate 79 equally ranked IID candidates
methylparaben	METHYLPARABEN	A2I8C7HI9T	SUSPENSION, EXTENDED RELEASE / ORAL		40 mg	Exact identifier — unii candidate 79 equally ranked IID candidates
glycerin	GLYCERIN	PDC6A3C0OX	SUPPOSITORY / RECTAL		440 mg	Exact identifier — unii candidate 75 equally ranked IID candidates
methylparaben	METHYLPARABEN	A2I8C7HI9T	LIQUID / ORAL		162 mg	Exact identifier — unii candidate 79 equally ranked IID candidates
methylparaben	METHYLPARABEN	A2I8C7HI9T	SHAMPOO / TOPICAL	0.15 %w/w		Exact identifier — unii candidate 79 equally ranked IID candidates
sodium hydroxide	SODIUM HYDROXIDE	55X04QC32I	INJECTION / INTRACAVITARY	ADJ PH		Exact identifier — unii candidate 174 equally ranked IID candidates
methylparaben	METHYLPARABEN	A2I8C7HI9T	INJECTION, POWDER, FOR SOLUTION / INTRAVENOUS	15 mg		Exact identifier — unii candidate 79 equally ranked IID candidates
glycerin	GLYCERIN	PDC6A3C0OX	INJECTION / INTRADERMAL	1.6 %w/v		Exact identifier — unii candidate 75 equally ranked IID candidates
glycerin	GLYCERIN	PDC6A3C0OX	DROPS / ORAL	300 mg/1ml		Exact identifier — unii candidate 75 equally ranked IID candidates
glycerin	GLYCERIN	PDC6A3C0OX	TABLET, CHEWABLE / ORAL		12 mg	Exact identifier — unii candidate 75 equally ranked IID candidates
methylparaben	METHYLPARABEN	A2I8C7HI9T	GEL / TOPICAL		24 mg	Exact identifier — unii candidate 79 equally ranked IID candidates
methylparaben	METHYLPARABEN	A2I8C7HI9T	INJECTION, SOLUTION / EPIDURAL		30 mg	Exact identifier — unii candidate 79 equally ranked IID candidates
sorbic acid	SORBIC ACID	X045WJ989B	TABLET, DELAYED RELEASE / ORAL	0.03 mg		Exact identifier — unii candidate 19 equally ranked IID candidates
methylparaben	METHYLPARABEN	A2I8C7HI9T	CREAM, AUGMENTED / TOPICAL		2 mg	Exact identifier — unii candidate 79 equally ranked IID candidates
glycerin	GLYCERIN	PDC6A3C0OX	SOLUTION / AURICULAR (OTIC)	63.64 %w/v		Exact identifier — unii candidate 75 equally ranked IID candidates
sodium hydroxide	SODIUM HYDROXIDE	55X04QC32I	GEL / TRANSDERMAL		472 mg	Exact identifier — unii candidate 174 equally ranked IID candidates
glycerin	GLYCERIN	PDC6A3C0OX	CREAM / TOPICAL		1720 mg	Exact identifier — unii candidate 75 equally ranked IID candidates
sodium hydroxide	SODIUM HYDROXIDE	55X04QC32I	SUSPENSION / ORAL	400 mg		Exact identifier — unii candidate 174 equally ranked IID candidates
methylparaben	METHYLPARABEN	A2I8C7HI9T	SOLUTION / IONTOPHORESIS	0.1 %w/v		Exact identifier — unii candidate 79 equally ranked IID candidates
sodium hydroxide	SODIUM HYDROXIDE	55X04QC32I	SUSPENSION, EXTENDED RELEASE / INTRASYNOVIAL	ADJ PH		Exact identifier — unii candidate 174 equally ranked IID candidates
stearic acid	STEARIC ACID	4ELV7Z65AP	TABLET, EXTENDED RELEASE / ORAL		200 mg	Exact identifier — unii candidate 26 equally ranked IID candidates
sodium hydroxide	SODIUM HYDROXIDE	55X04QC32I	INJECTION, EMULSION / INTRAVENOUS	ADJ PH		Exact identifier — unii candidate 174 equally ranked IID candidates
magnesium stearate	MAGNESIUM STEARATE	70097M6I30	IMPLANT / SUBCUTANEOUS	0.5 mg		Exact identifier — unii candidate 39 equally ranked IID candidates
sodium hydroxide	SODIUM HYDROXIDE	55X04QC32I	INJECTION / INTRASPINAL	ADJ PH		Exact identifier — unii candidate 174 equally ranked IID candidates
methylparaben	METHYLPARABEN	A2I8C7HI9T	GRANULE, FOR SUSPENSION / ORAL		80 mg	Exact identifier — unii candidate 79 equally ranked IID candidates
sodium hydroxide	SODIUM HYDROXIDE	55X04QC32I	POWDER, FOR SOLUTION / ORAL	ADJ PH		Exact identifier — unii candidate 174 equally ranked IID candidates
sorbic acid	SORBIC ACID	X045WJ989B	TABLET, FILM COATED / ORAL		5 mg	Exact identifier — unii candidate 19 equally ranked IID candidates
methylparaben	METHYLPARABEN	A2I8C7HI9T	CREAM / VAGINAL		22 mg	Exact identifier — unii candidate 79 equally ranked IID candidates
sodium hydroxide	SODIUM HYDROXIDE	55X04QC32I	SOLUTION / IRRIGATION	ADJ PH		Exact identifier — unii candidate 174 equally ranked IID candidates
sodium hydroxide	SODIUM HYDROXIDE	55X04QC32I	INJECTION, SUSPENSION / SOFT TISSUE	ADJ PH		Exact identifier — unii candidate 174 equally ranked IID candidates
glycerin	GLYCERIN	PDC6A3C0OX	TABLET / ORAL		42 mg	Exact identifier — unii candidate 75 equally ranked IID candidates
sodium hydroxide	SODIUM HYDROXIDE	55X04QC32I	CAPSULE, LIQUID FILLED / ORAL	1.5 mg		Exact identifier — unii candidate 174 equally ranked IID candidates
methylparaben	METHYLPARABEN	A2I8C7HI9T	SUSPENSION/ DROPS / OPHTHALMIC	0.05 %w/w		Exact identifier — unii candidate 79 equally ranked IID candidates
sodium hydroxide	SODIUM HYDROXIDE	55X04QC32I	AEROSOL, METERED / RESPIRATORY (INHALATION)	ADJ PH		Exact identifier — unii candidate 174 equally ranked IID candidates
glycerin	GLYCERIN	PDC6A3C0OX	GEL / OPHTHALMIC	0.88 %w/w		Exact identifier — unii candidate 75 equally ranked IID candidates
glycerin	GLYCERIN	PDC6A3C0OX	SPRAY / NASAL	22.3 mg/1ml		Exact identifier — unii candidate 75 equally ranked IID candidates
stearic acid	STEARIC ACID	4ELV7Z65AP	OINTMENT / TOPICAL	15 %w/w		Exact identifier — unii candidate 26 equally ranked IID candidates
glycerin	GLYCERIN	PDC6A3C0OX	EMULSION / INTRAVENOUS	2.2 %w/v		Exact identifier — unii candidate 75 equally ranked IID candidates
glycerin	GLYCERIN	PDC6A3C0OX	INJECTION, SOLUTION / INTRAMUSCULAR	15 %w/v		Exact identifier — unii candidate 75 equally ranked IID candidates
sorbic acid	SORBIC ACID	X045WJ989B	SUSPENSION / ORAL		40 mg	Exact identifier — unii candidate 19 equally ranked IID candidates
sodium hydroxide	SODIUM HYDROXIDE	55X04QC32I	SUSPENSION / OPHTHALMIC	ADJ PH		Exact identifier — unii candidate 174 equally ranked IID candidates
glycerin	GLYCERIN	PDC6A3C0OX	SYSTEM / IONTOPHORESIS	168.1 mg		Exact identifier — unii candidate 75 equally ranked IID candidates
methylparaben	METHYLPARABEN	A2I8C7HI9T	SOLUTION / IRRIGATION	2 %w/v		Exact identifier — unii candidate 79 equally ranked IID candidates
sodium hydroxide	SODIUM HYDROXIDE	55X04QC32I	INJECTION / SUBCUTANEOUS	31.45 mg		Exact identifier — unii candidate 174 equally ranked IID candidates
methylparaben	METHYLPARABEN	A2I8C7HI9T	SUSPENSION / ORAL		388 mg	Exact identifier — unii candidate 79 equally ranked IID candidates
sodium hydroxide	SODIUM HYDROXIDE	55X04QC32I	CONCENTRATE / ORAL	10 mg/5ml		Exact identifier — unii candidate 174 equally ranked IID candidates
methylparaben	METHYLPARABEN	A2I8C7HI9T	INJECTION / INTRALESIONAL	0.15 %w/v		Exact identifier — unii candidate 79 equally ranked IID candidates
glycerin	GLYCERIN	PDC6A3C0OX	SUSPENSION / ORAL		26208 mg	Exact identifier — unii candidate 75 equally ranked IID candidates
magnesium stearate	MAGNESIUM STEARATE	70097M6I30	TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE / ORAL		47 mg	Exact identifier — unii candidate 39 equally ranked IID candidates
sodium hydroxide	SODIUM HYDROXIDE	55X04QC32I	SOLUTION / PERIODONTAL	ADJ PH		Exact identifier — unii candidate 174 equally ranked IID candidates
sodium hydroxide	SODIUM HYDROXIDE	55X04QC32I	SUSPENSION, EXTENDED RELEASE / INTRADERMAL	ADJ PH		Exact identifier — unii candidate 174 equally ranked IID candidates
methylparaben	METHYLPARABEN	A2I8C7HI9T	INJECTION / PARENTERAL		18 mg	Exact identifier — unii candidate 79 equally ranked IID candidates
glycerin	GLYCERIN	PDC6A3C0OX	EMULSION / OPHTHALMIC		3 mg	Exact identifier — unii candidate 75 equally ranked IID candidates
magnesium stearate	MAGNESIUM STEARATE	70097M6I30	TABLET, DELAYED RELEASE / ORAL		144 mg	Exact identifier — unii candidate 39 equally ranked IID candidates

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
255ddf24-7e33-471d-ab91-bc98652e760a			9b3c7b34-abd9-417b-a2e9-b7e857339ff5	2010-08-24	Warnings	Exact identifier spl id: 255ddf24-7e33-471d-ab91-bc98652e760a spl set id: 9b3c7b34-abd9-417b-a2e9-b7e857339ff5

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.